☰

Evan Herrmann, PhD - Publications

Affiliations: 
Columbia University, New York, NY 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Haney M, Bedi G, Cooper ZD, Herrmann ES, Reed SC, Foltin RW, Kingsley PJ, Marnett LJ, Patel S. Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers. Addiction Biology. 27: e13183. PMID 35754107 DOI: 10.1111/adb.13183  0.385
2022 Kearney-Ramos T, Herrmann ES, Belluomo I, Matias I, Vallée M, Monlezun S, Piazza PV, Haney M. The Relationship Between Circulating Endogenous Cannabinoids and the Effects of Smoked Cannabis. Cannabis and Cannabinoid Research. PMID 35486827 DOI: 10.1089/can.2021.0185  0.349
2020 Schlienz NJ, Spindle TR, Cone EJ, Herrmann ES, Bigelow GE, Mitchell JM, Flegel R, LoDico C, Vandrey R. Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis. Drug and Alcohol Dependence. 211: 107969. PMID 32298998 DOI: 10.1016/J.Drugalcdep.2020.107969  0.403
2019 Montgomery L, Mantey DS, Peters EN, Herrmann ES, Winhusen T. Blunt use and menthol cigarette smoking: An examination of adult marijuana users. Addictive Behaviors. 102: 106153. PMID 31704435 DOI: 10.1016/J.Addbeh.2019.106153  0.343
2018 McClure EA, Tomko RL, Salazar CA, Akbar SA, Squeglia LM, Herrmann E, Carpenter MJ, Peters EN. Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences. Experimental and Clinical Psychopharmacology. PMID 30556733 DOI: 10.1037/Pha0000244  0.393
2018 Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse. Addiction Biology. PMID 30378231 DOI: 10.1111/Adb.12664  0.529
2018 Haney M, Cooper ZD, Bedi G, Herrmann E, Comer SD, Reed SC, Foltin RW, Levin FR. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Addiction Biology. PMID 29659126 DOI: 10.1111/Adb.12621  0.513
2018 Vandrey R, Budney A, Herrmann E, Schlienz N, Hampson A, Smith M, Stitzer M. 166. Targeting Sleep Disturbance in the Treatment of Cannabis Use Disorders Biological Psychiatry. 83: S67. DOI: 10.1016/J.Biopsych.2018.02.184  0.371
2017 Herrmann ES, Cooper Z, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin R, Haney M. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and relapse among non-treatment-seeking cannabis users Drug and Alcohol Dependence. 171: e88. DOI: 10.1016/J.Drugalcdep.2016.08.247  0.554
2016 Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users. Psychopharmacology. PMID 27085870 DOI: 10.1007/S00213-016-4298-6  0.562
2015 Herrmann ES, Weerts E, Vandrey R. Gender differences in cannabis withdrawal symptoms among treatment-seeking cannabis users Drug and Alcohol Dependence. 156: e95. DOI: 10.1016/J.Drugalcdep.2015.07.1175  0.402
2015 Vandrey R, Budney AJ, Smith M, Herrmann E, Hampson A, Stitzer M. A pilot study of zolpidem pharmacotherapy in the treatment of cannabis use disorders Drug and Alcohol Dependence. 146: e10. DOI: 10.1016/J.Drugalcdep.2014.09.708  0.359
Show low-probability matches.